Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Wu Zhong and Manli Wang.
Wu Zhong
Connection Strength
1.335
Manli Wang
  1. Pathological features of COVID-19-associated liver injury-a preliminary proteomics report based on clinical samples. Signal Transduct Target Ther. 2021 01 08; 6(1):9.
    View in: PubMed
    Score: 0.231
  2. Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro. Virol Sin. 2020 Dec; 35(6):776-784.
    View in: PubMed
    Score: 0.226
  3. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro. ACS Infect Dis. 2020 09 11; 6(9):2524-2531.
    View in: PubMed
    Score: 0.225
  4. The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro. Cell Discov. 2020; 6:28.
    View in: PubMed
    Score: 0.220
  5. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020; 6:16.
    View in: PubMed
    Score: 0.218
  6. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 03; 30(3):269-271.
    View in: PubMed
    Score: 0.216
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.